Search

Search Constraints

You searched for: Author/Creator Créhange, G.

Search Results

1. Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial – PROFIT. (August 2022)

7. In-vivo and in-vitro impact of high-dose rate radiotherapy using flattening-filter-free beams on the anti-tumor immune response. (September 2020)

8. MO-0058 Cost-effectiveness of hypofractionated radiotherapy in intermediate-risk prostate cancer. (May 2022)

9. OC-0108 Impact of the Radiation Therapy Quality Assurance in the phase II/III CONCORDE trial. (May 2022)